Palo Alto Investors LP Biogen Inc. Transaction History

Palo Alto Investors LP

$727 Million
Q3 2024

A detailed history of Palo Alto Investors LP transactions in Biogen Inc. stock. As of the latest transaction made, Palo Alto Investors LP holds 228,916 shares of BIIB stock, worth $34.1 Million. This represents 6.1% of its overall portfolio holdings.

Number of Shares

228,916

Previous 289,050 20.8%

Holding current value

$34.1 Million

Previous $67 Million 33.78%

% of portfolio

6.1%

Previous 8.48%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$189.07 - $236.8 $11.4 Million - $14.2 Million	-60,134 Reduced 20.8%	228,916 $44.4 Million
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $172,992 - $214,941	-908 Reduced 0.31%	289,050 $67 Million
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $19.2 Million - $24.2 Million	-90,459 Reduced 23.78%	289,958 $62.5 Million
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $192,540 - $231,768	-865 Reduced 0.23%	380,417 $98.4 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $307,872 - $350,807	1,200 Added 0.32%	381,282 $106 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $4.82 Million - $5.86 Million	19,101 Added 5.29%	380,082 $105 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $4.65 Million - $5.86 Million	-24,019 Reduced 6.24%	360,981 $76 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $5.24 Million - $6.73 Million	23,400 Added 6.47%	385,000 $92.4 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $4.77 Million - $7.63 Million	18,400 Added 5.36%	361,600 $125 Million
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $26.5 Million - $31 Million	108,900 Added 46.48%	343,200 $96 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $55.4 Million - $83.3 Million	234,300 New	234,300 $57.4 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Palo Alto Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Palo Alto Investors LP with notifications on news.

Account

Palo Alto Investors LP Biogen Inc. Transaction History